UnitedHealth Group Incorporated $UNH Stock: AIA Group Ltd Decreases Position

Key Points

• AIA Group cut its UnitedHealth stake by 8.9% in the third quarter, selling 9,534 shares and retaining 97,127 shares valued at about $35.7 million.
• UnitedHealth beat quarterly earnings and revenue estimates: it reported EPS of $4.69 versus $4.14 expected and revenue of $112.72 billion versus $111.31 billion expected. The company set fiscal 2026 EPS guidance at $20.50, while analysts estimate $20.61.
• Analyst sentiment remains positive: 20 analysts rate the stock Buy and eight Hold, resulting in a “Moderate Buy” consensus and an average target price of $463.93.

AIA Group Ltd decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 97,127 shares of the healthcare conglomerate's stock after selling 9,534 shares during the period. AIA Group Ltd's holdings in UnitedHealth Group were worth $35,653,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. Corient Private Wealth LP bought a new position in shares of UnitedHealth Group in the second quarter worth $245,516,000. Legal & General Group Plc purchased a new position in UnitedHealth Group during the 2nd quarter valued at about $2,444,928,000. Jupiter Topco LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at about $2,019,844,000. BlackRock Inc. lifted its holdings in shares of UnitedHealth Group by 4.6% in the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock worth $31,946,594,000 after buying an additional 3,395,530 shares in the last quarter. Finally, Canada Pension Plan Investment Board bought a new position in shares of UnitedHealth Group in the second quarter valued at approximately $971,757,000. Institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research analyst reports. Raymond James Financial restated an "outperform" rating and issued a $450.00 target price on shares of UnitedHealth Group in a research note on Thursday, October 15th. Bank of America reiterated a "buy" rating and set a $450.00 price target on shares of UnitedHealth Group in a research report on Monday, July 20th. Sanford C. Bernstein cut their price objective on UnitedHealth Group from $512.00 to $500.00 and set an "outperform" rating for the company in a report on Wednesday, October 14th. UBS Group reaffirmed an "outperform" rating on shares of UnitedHealth Group in a research note on Tuesday, October 13th. Finally, Stephens set a $500.00 target price on shares of UnitedHealth Group in a research report on Friday, October 16th. Twenty research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $463.93.

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the company's stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 0.19% of the company's stock.

UnitedHealth Group Trading Up 0.7%

UNH opened at $403.10 on Wednesday. The business has a 50 day simple moving average of $390.47 and a two-hundred day simple moving average of $363.08. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62. The firm has a market capitalization of $361.81 billion, a price-to-earnings ratio of 19.62, a PEG ratio of 1.45 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating analysts' consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same quarter in the previous year, the firm posted $2.59 EPS. The company's revenue for the quarter was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts predict that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were given a $2.32 dividend. The ex-dividend date was Monday, September 14th. This represents a $9.28 annualized dividend and a yield of 2.3%. UnitedHealth Group's dividend payout ratio (DPR) is presently 53.00%.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Earnings and outlook are key tailwinds. UnitedHealth’s quarterly EPS and revenue beat analysts’ estimates, and the company raised its 2026 profit outlook. Those results helped drive an approximately 11% share gain over the month through October 30. UnitedHealth Just Gained 11% in a Month: Take Profits, or Buy More?
• Positive Sentiment: Buying and value-oriented endorsements provide support. ETFs recorded net purchases of UnitedHealth shares, including $35 million in buying on October 29. BetterInvesting Magazine also named UNH its “Undervalued Stock,” though such selections are not a guarantee of future performance. UnitedHealth Group Draws ETF Buying BetterInvesting Magazine Update
• Neutral Sentiment: Optum Insight’s AI investment is a longer-term opportunity with execution risk. UnitedHealth is expanding AI tools to improve efficiency and claims processing, but rising costs mean the spending still needs to translate into profit growth. Will UNH’s Optum Insight Spending Translate Into Profit Growth?
• Negative Sentiment: Political scrutiny could weigh on sentiment. Senator Elizabeth Warren criticized the Trump administration’s approval of UnitedHealth’s $3.3 billion Amedisys acquisition, arguing the deal increases the company’s power over costs and patient care. The comments renew attention to potential regulatory and political risks. Elizabeth Warren Criticizes UnitedHealth’s Amedisys Deal

About UnitedHealth Group

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.